A Novel Approach Integrating Magnetic Resonance Imaging (MRI) Data and Artificial Intelligence for Predicting the Success Rate of Vaginal Delivery in Pregnant Women
1 other identifier
observational
200
1 country
1
Brief Summary
The aim of this study was to use MRI imaging to accurately scan the pregnant woman's pelvis and fetal skull, build a 3D model of them, and combine with artificial intelligence to develop an accurate tool to predict the success rate of vaginal delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
September 21, 2023
September 1, 2023
2.7 years
September 12, 2023
September 12, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The mode of delivery
Vaginal or cesarean delivery in the end
during delivery
Study Arms (1)
Vaginal trial labor group
Interventions
The pelvic parameters and fetal head parameters of pregnant women were measured by MRI, including pelvic entrance plane, middle pelvic plane, pelvic outlet plane, pubic arch Angle, double parietal diameter, occipitofrontal diameter, and suboccipital fontanel diameter.
Eligibility Criteria
Full-term single live pregnant women who gave birth in the Department of Obstetrics of the Second Affiliated Hospital of Wenzhou Medical University from January 1, 2024 to December 31, 2026 were selected as the study population
You may qualify if:
- Full-term.
- Single fetus, head first.
- Pregnant women have vaginal couvade wishes.
- Complete clinical data of pregnant women.
You may not qualify if:
- Pregnancy with serious medical and surgical diseases.
- Abnormal fetal position (such as transverse, breech, etc.).
- Twin or multiple pregnancies.
- Vaginal couvade contraindications such as placenta previa.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, 325027, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2023
First Posted
September 21, 2023
Study Start
January 1, 2024
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
September 21, 2023
Record last verified: 2023-09